Status:
UNKNOWN
Recovery After Critical Covid-19 Infection
Lead Sponsor:
University of Helsinki
Collaborating Sponsors:
Uppsala University
Göteborg University
Conditions:
Covid-19
Eligibility:
All Genders
18-100 years
Brief Summary
The study focuses on the recovery of respiratory, cardiovascular and neurological/neuropsychological recovery after intensive care treatment for covid-19. The results will be compared with those obtai...
Detailed Description
Eligible patients who have been treated in the intensive care units of Helsinki University Hospital are invited to participate. Controls are recruited from follow-up clinics, and with announcements in...
Eligibility Criteria
Inclusion
- Age 18-100
- Positive PCR for Sars-CoV-2 (except non-covid controls, who must be negative)
- Native language Finnish or Swedish
- Informed consent to study to study participation
Exclusion
- Age under 18
- Pregnant or lactating
- Major neurologic diagnosis (TBI, dementia, stroke, Parkinson´s disease before covid-19)
- Substantially impaired hearing or vision
- Developmental disability.
- No consent to study participation
- Contraindication to MR imaging (such as cardiac pacemaker, allergy to contrast)
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 25 2024
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04864938
Start Date
August 1 2020
End Date
July 25 2024
Last Update
April 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Hospital
Helsinki, Capital Province of Finland, Finland, 00290